# Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation

> **NCT00793351** · PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **PROCEDURE:** Reduced-intensity allogeneic hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00793351
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-11
- **Final completion:** 2015-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793351, "Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00793351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*